Charité - Universitätsmedizin Berlin

Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry (2017) Wallwiener M, Heindl F, Brucker SY, Taran FA, Hartkopf A, Overkamp F, Kolberg HC, et al. Journal article Report of the 24th annual conference of the Working Group Kidney Transplantation of the German Society of Urology in Erlangen (2017) Apel H, Putz J, Fornara P, Friedersdorff F, Dreikorn K, Stoeckle M, Wullich B Journal article, Report Influence of female sex and fertile age on neuromyelitis optica spectrum disorders (2017) Borisow N, Kleiter I, Gahlen A, Fischer K, Wernecke KD, Pache F, Ruprecht K, et al. Journal article Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response (2017) Stellmann JP, Krumbholz M, Friede T, Gahlen A, Borisow N, Fischer K, Hellwig K, et al. Journal article CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial (2017) Sinn M, Bahra M, Liersch T, Gellert K, Messmann H, Bechstein W, Waldschmidt D, et al. Journal article Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial (2017) Diener MK, Huettner FJ, Kieser M, Knebel P, Doerr-Harim C, Distler M, Grützmann R, et al. Journal article A Comparison of Aspergillus and Mucorales PCR Testing of Different BAL Fractions from Patients with Suspected Invasive Pulmonary Fungal Disease (2017) Springer J, White PL, Kessel J, Wieters I, Teschner D, Korczynski D, Liebregts T, et al. Journal article Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology (2017) Ripperger T, Bielack SS, Borkhardt A, Brecht IB, Burkhardt B, Calaminus G, Debatin KM, et al. Journal article Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants (2017) Hehlmann R, Lauseker M, Saussele S, Pfirrmann M, Krause S, Kolb HJ, Neubauer A, et al. Journal article Allogeneic Hematopoietic Cell Transplantation in Intermediate Risk Acute Myeloid Leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA Mutations (2017) Heidrich K, Thiede C, Schaefer-Eckart K, Schmitz N, Aulitzky WE, Kraemer A, Rösler W, et al. Journal article